Could Andy Burnham as Prime Minister Shift the UK Towards Cannabis Legalisation?

Britain may be heading for a change at the top of government, and with it comes renewed debate about whether a new Prime Minister could finally break the UK's decades-long deadlock on cannabis reform.

Greater Manchester mayor Andy Burnham is widely discussed as a potential successor to the current Labour leadership, positioning himself as a plain-speaking figure to the left of the party's Westminster establishment. For cannabis campaigners, the question is not simply who occupies Number 10 — but whether that person would have the political capital and appetite to treat legalisation as a serious policy option rather than a fringe talking point.

Burnham's record: reform curious, but cautious

Burnham has not embraced cannabis legalisation in the way London mayor Sadiq Khan has. When Khan pushed ahead with plans for a London drugs commission — despite opposition from Labour leader Keir Starmer — Burnham struck a more cautious note.

"I don't think we'd want to see, if I'm honest, that type of change at this moment in time. I think it would be a hard sell," Burnham said at the time, distancing himself from Khan's more open approach.

That hesitation matters. Burnham has built a reputation on evidence-led public service reform and harm reduction, including his advocacy for better funding to address record drug deaths and his work on Greater Manchester's integrated approach to problematic substance use. Yet on recreational cannabis specifically, he has aligned publicly with the caution of the national party rather than championing reform outright.

Some analysts suggest that distance reflected political positioning as much as conviction — allowing Khan to own the reform agenda while Burnham preserved room to manoeuvre. Whether that room would translate into action from Downing Street is another question entirely.

The economic case is harder to ignore

Even politicians sceptical of cultural arguments for reform face a growing fiscal case. The Transform Drug Policy Foundation's 2025 report, High Returns, estimated that legalising and regulating adult-use cannabis could generate up to £1.5 billion in annual net benefits to the Treasury — roughly £1.1 billion in tax revenue, £284 million in criminal justice savings, and more than 15,500 new jobs.

The UK illicit recreational market is thought to be worth around £2 billion a year, with proceeds flowing to unregulated suppliers and organised crime rather than public services. Conservative MPs and business figures have begun engaging with those numbers, not because they have become overnight converts to cannabis culture, but because the status quo increasingly looks like an expensive failure of regulation.

For a incoming government seeking to fund visible progressive priorities without raising income tax, ring-fenced cannabis revenue has obvious appeal — whether directed at NHS waiting lists, youth mental health services, or local prevention programmes.

Public opinion has moved — Westminster has not

Polling suggests the electorate is closer to reform than many MPs assume. YouGov's 2026 research found Britons split 47% to 43% on a straight legalisation question, with a further 23% favouring decriminalisation when offered three options. Combined, a majority supports moving beyond pure criminalisation.

That gap between public mood and parliamentary inertia is precisely what reform advocates say a bold new leader could exploit. Drug policy has long been treated as a "third rail" issue — touch it and face tabloid backlash. Yet successive surveys show younger voters, and increasingly the middle-aged, view cannabis prohibition as outdated rather than protective.

Campaigners including Charlotte Caldwell, whose advocacy helped secure the 2018 legalisation of medical cannabis, have argued that controlled reform is the credible alternative to a black market supplying ever-stronger products with no quality standards or age controls.

What a Burnham government might actually do

Speculation about a Burnham premiership should be treated carefully. No leadership contest has concluded, and Burnham has not published a cannabis legalisation manifesto. But the policy space available to a Prime Minister willing to move is clearer than it was a decade ago.

Short of full legalisation, a government could commission an independent review modelled on Khan's London process but with national scope, decriminalise personal possession as a first step, or pilot regulated adult-use sales in devolved areas — learning from frameworks in Canada, Germany and several US states.

A more ambitious package could pair regulation with public health investment: taxing legal sales while restricting high-potency products, enforcing age verification, banning advertising to minors, and directing revenue towards children's mental health services — where NHS waiting lists remain stubbornly long.

Critics would be swift. Right-wing commentators would relish the chance to caricature a reforming Labour leader. Burnham would need confidence, detailed fiscal modelling, and support from trade unions and public health bodies to withstand that pressure.

The potency problem cannot be sidestepped

Any serious reform debate in the UK must grapple with product strength. Medical and illicit markets alike have shifted towards high-THC cannabis, with concerns about psychosis and youth mental health driving much of the medical establishment's scepticism — a tension highlighted in recent Lancet Psychiatry research on commercial cannabis markets abroad.

Legalisation without strict potency caps, marketing rules and public health safeguards would be a harder sell to parents, teachers and NHS clinicians. A Burnham — or any — government would need to demonstrate it had learned from North American commercialisation mistakes rather than repeating them.

Reform window or more of the same?

Burnham's past quote — that legalisation would be "a hard sell" — may still reflect his private assessment. Equally, leaders often sound more cautious in opposition or at mayor level than they govern in practice, especially when fiscal and electoral incentives align.

What seems clear is that the conditions for a national conversation have rarely been stronger: public support near parity, a mature medical cannabis sector, growing cross-party interest in the economic case, and an illicit market that continues regardless of enforcement.

Whether Britain's next Prime Minister seizes that moment — or leaves cannabis policy frozen for another parliamentary term — may depend less on ideology than on whether they believe voters are ready for a government that treats the issue as regulation and public health, not moral panic.